Question 1

What specific information will be collected about my treatment experience?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the bIosimilar of aDalimumab, an European evAluation clinical trial (NCT05190484). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this study help improve treatment options for patients like me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the bIosimilar of aDalimumab, an European evAluation clinical trial (NCT05190484). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential risks or benefits of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the bIosimilar of aDalimumab, an European evAluation clinical trial (NCT05190484). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the study site, and what will those visits involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the bIosimilar of aDalimumab, an European evAluation clinical trial (NCT05190484). Contact the study team or your healthcare provider for specific answers.

Question 5

Can I continue my current treatment plan while participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the bIosimilar of aDalimumab, an European evAluation clinical trial (NCT05190484). Contact the study team or your healthcare provider for specific answers.

What this study is about